Cargando…
Clinical research advances of isavuconazole in the treatment of invasive fungal diseases
PURPOSE: Invasive fungal diseases (IFD) are a major global public health concern. The incidence of IFD has increased the demand for antifungal agents. Isavuconazole (ISA) is a new triazole antifungal agent that has shown promising efficacy in the prophylaxis and treatment of invasive fungal diseases...
Autores principales: | Zhang, Tingting, Shen, Yuyan, Feng, Sizhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751058/ https://www.ncbi.nlm.nih.gov/pubmed/36530445 http://dx.doi.org/10.3389/fcimb.2022.1049959 |
Ejemplares similares
-
In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species
por: Schwarz, Patrick, et al.
Publicado: (2022) -
Editorial: Invasive fungal disease in the immunocompromised host/Research Topic proceedings of the mycology 2021 meeting
por: Agrawal, Samir, et al.
Publicado: (2022) -
Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes
por: Guo, Wenjing, et al.
Publicado: (2023) -
Application of metagenomic next-generation sequencing in the diagnosis of pulmonary invasive fungal disease
por: Wang, Chengtan, et al.
Publicado: (2022) -
Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases
por: Zhen, Sisi, et al.
Publicado: (2023)